OurBio Agrees to Stock Merger and Articles of Incorporation Amendments at Special Shareholders' Meeting

OurBio (082850), a health supplement company, approved both stock merger approval and partial articles of incorporation amendment proposals at its special shareholders' meeting on July 15, 2026, and announced the results. The merger consolidates ordinary shares from 500 won to 2,500 won per share, with 99.3% shareholder approval based on exercised shares. The amendments, also approved with 99.3% support, address regulatory updates related to the stock merger. As of December 2025 financial statements, the company reported total assets of 761.9 billion won, liabilities of 500.6 billion won, and a net loss of 102 billion won. OurBio, listed on KOSDAQ since July 29, 2005, saw its stock price rise 6.15% to 1,139 won on July 15, 2026.